Latest Articles

Publication Date
Older singles are having fun, new eharmony report finds - Mashable

Older singles are having fun, new eharmony report finds Mashable

Published: April 22, 2026, 9:50 p.m.
Gimbe report on endometriosis: "Up to 10 years for a diagnosis." - lamilano.it

Gimbe report on endometriosis: "Up to 10 years for a diagnosis." lamilano.it

Published: April 21, 2026, 10:31 a.m.
Christina Applegate Gives Update On Her Health After SCARY Hospitalization Reports - perezhilton.com

Christina Applegate Gives Update On Her Health After SCARY Hospitalization Reports perezhilton.com

Published: April 20, 2026, 10:12 p.m.
As US birth rate falls, feds' response may make pregnancy more dangerous - The Lund Report

As US birth rate falls, feds' response may make pregnancy more dangerous The Lund Report

Published: April 16, 2026, 9:32 p.m.
BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - BioPharm International

BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer BioPharm International

Published: April 15, 2026, 10:02 p.m.
The Fallout With Jack, Jenni and Adam: Five Takeaways From Lena Dunham’s Memoir ‘Famesick’ - The Hollywood Reporter

The Fallout With Jack, Jenni and Adam: Five Takeaways From Lena Dunham’s Memoir ‘Famesick’ The Hollywood Reporter

Published: April 14, 2026, 2:58 p.m.
Jes Burns and Brook Herbert win national award for reporting on cancer research - Oregon Public Broadcasting - OPB

Jes Burns and Brook Herbert win national award for reporting on cancer research Oregon Public Broadcasting - OPB

Published: April 13, 2026, 11:38 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks

BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks

Published: April 13, 2026, 12:29 p.m.
GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer - Stock Titan

GSK (NYSE: GSK) reports Mo-Rez data in ovarian, endometrial cancer Stock Titan

Published: April 13, 2026, 10:23 a.m.
GSK reports promising early results in ovarian and womb cancer drug trial - The Guardian

GSK reports promising early results in ovarian and womb cancer drug trial The Guardian

Published: April 12, 2026, 10:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!